Your browser doesn't support javascript.
loading
Dynamic clade transitions and the influence of vaccination on the spatiotemporal circulation of SARS-CoV-2 variants.
Banho, Cecília Artico; de Carvalho Marques, Beatriz; Sacchetto, Lívia; Lima, Ana Karoline Sepedro; Parra, Maisa Carla Pereira; Lima, Alex Ranieri Jeronimo; Ribeiro, Gabriela; Martins, Antonio Jorge; Barros, Claudia Renata Dos Santos; Elias, Maria Carolina; Sampaio, Sandra Coccuzzo; Slavov, Svetoslav Nanev; Rodrigues, Evandra Strazza; Santos, Elaine Vieira; Covas, Dimas Tadeu; Kashima, Simone; Brassaloti, Ricardo Augusto; Petry, Bruna; Clemente, Luan Gaspar; Coutinho, Luiz Lehmann; Assato, Patricia Akemi; da Silva da Costa, Felipe Allan; Grotto, Rejane Maria Tommasini; Poleti, Mirele Daiana; Lesbon, Jessika Cristina Chagas; Mattos, Elisangela Chicaroni; Fukumasu, Heidge; Giovanetti, Marta; Alcantara, Luiz Carlos Junior; Souza-Neto, Jayme A; Rahal, Paula; Araújo, João Pessoa; Spilki, Fernando Rosado; Althouse, Benjamin M; Vasilakis, Nikos; Nogueira, Maurício Lacerda.
Afiliação
  • Banho CA; Laboratório de Pesquisas em Virologia, Faculdade de Medicina de São José do Rio Preto; São José do Rio Preto, São Paulo, Brazil.
  • de Carvalho Marques B; Laboratório de Pesquisas em Virologia, Faculdade de Medicina de São José do Rio Preto; São José do Rio Preto, São Paulo, Brazil.
  • Sacchetto L; Laboratório de Pesquisas em Virologia, Faculdade de Medicina de São José do Rio Preto; São José do Rio Preto, São Paulo, Brazil.
  • Lima AKS; Laboratório de Pesquisas em Virologia, Faculdade de Medicina de São José do Rio Preto; São José do Rio Preto, São Paulo, Brazil.
  • Parra MCP; Laboratório de Pesquisas em Virologia, Faculdade de Medicina de São José do Rio Preto; São José do Rio Preto, São Paulo, Brazil.
  • Lima ARJ; Center for Viral Surveillance and Serological Assessment (CeVIVAS), Butantan Institute, São Paulo, Brazil.
  • Ribeiro G; Center for Viral Surveillance and Serological Assessment (CeVIVAS), Butantan Institute, São Paulo, Brazil.
  • Martins AJ; Center for Viral Surveillance and Serological Assessment (CeVIVAS), Butantan Institute, São Paulo, Brazil.
  • Barros CRDS; Center for Viral Surveillance and Serological Assessment (CeVIVAS), Butantan Institute, São Paulo, Brazil.
  • Elias MC; Center for Viral Surveillance and Serological Assessment (CeVIVAS), Butantan Institute, São Paulo, Brazil.
  • Sampaio SC; Center for Viral Surveillance and Serological Assessment (CeVIVAS), Butantan Institute, São Paulo, Brazil.
  • Slavov SN; Center for Viral Surveillance and Serological Assessment (CeVIVAS), Butantan Institute, São Paulo, Brazil.
  • Rodrigues ES; University of São Paulo, Ribeirão Preto Medical School, Blood Center of Ribeirão Preto, Ribeirão Preto, SP, Brazil.
  • Santos EV; University of São Paulo, Ribeirão Preto Medical School, Blood Center of Ribeirão Preto, Ribeirão Preto, SP, Brazil.
  • Covas DT; University of São Paulo, Ribeirão Preto Medical School, Blood Center of Ribeirão Preto, Ribeirão Preto, SP, Brazil.
  • Kashima S; Center for Viral Surveillance and Serological Assessment (CeVIVAS), Butantan Institute, São Paulo, Brazil.
  • Brassaloti RA; University of São Paulo, Ribeirão Preto Medical School, Blood Center of Ribeirão Preto, Ribeirão Preto, SP, Brazil.
  • Petry B; University of São Paulo, Ribeirão Preto Medical School, Blood Center of Ribeirão Preto, Ribeirão Preto, SP, Brazil.
  • Clemente LG; University of São Paulo, Centro de Genômica Funcional da ESALQ, Piracicaba, SP, Brazil.
  • Coutinho LL; University of São Paulo, Centro de Genômica Funcional da ESALQ, Piracicaba, SP, Brazil.
  • Assato PA; University of São Paulo, Centro de Genômica Funcional da ESALQ, Piracicaba, SP, Brazil.
  • da Silva da Costa FA; University of São Paulo, Centro de Genômica Funcional da ESALQ, Piracicaba, SP, Brazil.
  • Grotto RMT; São Paulo State University (UNESP), School of Agricultural Sciences, Department of Bioprocesses and Biotechnology, Botucatu, Brazil.
  • Poleti MD; São Paulo State University (UNESP), School of Agricultural Sciences, Department of Bioprocesses and Biotechnology, Botucatu, Brazil.
  • Lesbon JCC; São Paulo State University (UNESP), School of Agricultural Sciences, Botucatu, Brazil.
  • Mattos EC; Molecular Biology Laboratory, Applied Biotechnology Laboratory, Clinical Hospital of the Botucatu Medical School, Botucatu, Brazil.
  • Fukumasu H; Department of Veterinary Medicine, School of Animal Science and Food Engineering, University of São Paulo, Pirassununga, São Paulo, Brazil.
  • Giovanetti M; Department of Veterinary Medicine, School of Animal Science and Food Engineering, University of São Paulo, Pirassununga, São Paulo, Brazil.
  • Alcantara LCJ; Department of Veterinary Medicine, School of Animal Science and Food Engineering, University of São Paulo, Pirassununga, São Paulo, Brazil.
  • Souza-Neto JA; Department of Veterinary Medicine, School of Animal Science and Food Engineering, University of São Paulo, Pirassununga, São Paulo, Brazil.
  • Rahal P; Oswaldo Cruz Foundation, FIOCRUZ, Rio de Janeiro, Brazil.
  • Araújo JP; Climate Amplified Diseases And Epidemics (CLIMADE), Rio de Janeiro, Brazil.
  • Spilki FR; Sciences and Technologies for Sustainable Development and One Health, Universita Campus Bio-Medico di Roma, Selcetta, Italy.
  • Althouse BM; Oswaldo Cruz Foundation, FIOCRUZ, Rio de Janeiro, Brazil.
  • Vasilakis N; Climate Amplified Diseases And Epidemics (CLIMADE), Rio de Janeiro, Brazil.
  • Nogueira ML; Department of Diagnostic Medicine/Pathobiology, College of Veterinary Medicine, Kansas StateUniversity, Manhattan, KS, USA.
NPJ Vaccines ; 9(1): 145, 2024 Aug 10.
Article em En | MEDLINE | ID: mdl-39127725
ABSTRACT
Since 2021, the emergence of variants of concern (VOC) has led Brazil to experience record numbers of in COVID-19 cases and deaths. The expanded spread of the SARS-CoV-2 combined with a low vaccination rate has contributed to the emergence of new mutations that may enhance viral fitness, leading to the persistence of the disease. Due to limitations in the real-time genomic monitoring of new variants in some Brazilian states, we aimed to investigate whether genomic surveillance, coupled with epidemiological data and SARS-CoV-2 variants spatiotemporal spread in a smaller region, can reflect the pandemic progression at a national level. Our findings revealed three SARS-CoV-2 variant replacements from 2021 to early 2022, corresponding to the introduction and increase in the frequency of Gamma, Delta, and Omicron variants, as indicated by peaks of the Effective Reproductive Number (Reff). These distinct clade replacements triggered two waves of COVID-19 cases, influenced by the increasing vaccine uptake over time. Our results indicated that the effectiveness of vaccination in preventing new cases during the Delta and Omicron circulations was six and eleven times higher, respectively, than during the period when Gamma was predominant, and it was highly efficient in reducing the number of deaths. Furthermore, we demonstrated that genomic monitoring at a local level can reflect the national trends in the spread and evolution of SARS-CoV-2.

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: NPJ Vaccines Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Brasil

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: NPJ Vaccines Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Brasil